Overview

Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bayer
Criteria
Inclusion Criteria:

- At least 8 weeks post-documented myocardial infarction (heart attack)

Exclusion Criteria:

- History of radiation therapy to the chest

- Clinically unstable

- Any contraindication for MRI